NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 42 filers reported holding NABRIVA THERAPEUTICS PLC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $980,000 | -90.0% | 1,704,130 | -57.8% | 0.09% | -90.3% |
| Q2 2019 | $9,815,000 | -8.7% | 4,039,139 | -8.3% | 0.92% | -14.1% |
| Q1 2019 | $10,745,000 | +11.2% | 4,403,687 | -33.5% | 1.07% | -13.2% |
| Q4 2018 | $9,664,000 | -45.9% | 6,619,190 | 0.0% | 1.23% | -31.5% |
| Q3 2018 | $17,872,000 | +26.1% | 6,619,190 | +62.5% | 1.80% | -1.4% |
| Q2 2018 | $14,178,000 | -30.8% | 4,074,190 | 0.0% | 1.83% | -37.1% |
| Q1 2018 | $20,493,000 | -15.9% | 4,074,190 | 0.0% | 2.90% | -44.4% |
| Q4 2017 | $24,364,000 | -27.0% | 4,074,190 | 0.0% | 5.22% | -22.6% |
| Q3 2017 | $33,368,000 | – | 4,074,190 | – | 6.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 191,028 | $462,000 | 0.08% |
| Sterling Investment Advisors, Ltd. | 5,000 | $12,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |